Aspen Pharmacare Holdings Limited

JSE:APN 株式レポート

時価総額:R108.7b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Aspen Pharmacare Holdings 過去の業績

過去 基準チェック /26

Aspen Pharmacare Holdingsは、平均年間17.1%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間8% 3.3%収益成長率で 成長しています。 Aspen Pharmacare Holdingsの自己資本利益率は5.7%であり、純利益率は11.4%です。

主要情報

17.1%

収益成長率

17.6%

EPS成長率

Pharmaceuticals 業界の成長12.4%
収益成長率3.3%
株主資本利益率5.7%
ネット・マージン11.4%
次回の業績アップデート03 Sep 2024

最近の業績更新

Recent updates

We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

May 08
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Mar 05
Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Dec 22
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Dec 01
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Mar 31
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

Jan 11
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

Oct 22
These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Oct 06
We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Sep 21
Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Sep 08
Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Sep 07
Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Jun 15
Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

Apr 02
Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

Mar 16
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Mar 02
An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Dec 23
Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

Dec 02
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

Oct 11
We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Sep 30
After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

Sep 30
Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

収支内訳

Aspen Pharmacare Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

JSE:APN 収益、費用、利益 ( )ZAR Millions
日付収益収益G+A経費研究開発費
31 Dec 2342,7004,8689,7710
30 Sep 2341,7055,0489,5830
30 Jun 2340,7095,2289,3940
31 Mar 2339,5425,5159,1270
31 Dec 2238,3755,8028,8590
30 Sep 2238,4916,1458,6920
30 Jun 2238,6066,4888,5250
31 Mar 2238,5606,1858,6560
31 Dec 2138,5145,8818,7960
30 Sep 2138,1405,3408,9550
30 Jun 2137,7664,7989,1140
31 Mar 2135,7603,9548,8660
31 Dec 2036,3083,7829,0750
30 Sep 2034,9843,5818,9760
30 Jun 2033,6593,3808,8760
31 Mar 2039,9273,2729,9880
31 Dec 1933,6208708,9540
30 Sep 1934,5671,2759,1540
30 Jun 1935,5141,6799,3540
31 Mar 1936,8803,3509,6120
31 Dec 1836,6834,8909,5750
30 Sep 1837,4995,2569,5730
30 Jun 1838,3145,6219,5700
31 Mar 1839,6185,6829,6780
31 Dec 1740,9225,7439,7860
30 Sep 1741,0685,4369,6360
30 Jun 1741,2135,1289,4850
31 Mar 1739,5574,4149,2930
31 Dec 1637,9003,7009,1000
30 Sep 1636,7504,0008,8500
30 Jun 1635,6004,3008,6000
31 Mar 1635,5835,2208,5530
31 Dec 1535,5676,1408,5060
30 Sep 1535,8335,6708,5030
30 Jun 1536,1005,2008,5000
31 Mar 1535,8365,3698,0710
31 Dec 1435,5725,5377,6410
30 Sep 1432,5445,2726,8470
30 Jun 1429,5155,0086,0540
31 Mar 1425,9014,3885,2000
31 Dec 1322,2873,7684,3460
30 Sep 1320,7983,6444,0280
30 Jun 1319,3083,5203,7100

質の高い収益: APNは 高品質の収益 を持っています。

利益率の向上: APNの現在の純利益率 (11.4%)は、昨年(15.1%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: APNの収益は過去 5 年間で年間17.1%増加しました。

成長の加速: APNは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: APNは過去 1 年間で収益成長率がマイナス ( -16.1% ) となったため、 Pharmaceuticals業界平均 ( 3.6% ) と比較することが困難です。


株主資本利益率

高いROE: APNの 自己資本利益率 ( 5.7% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘